CellWell record HH-195408
Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer
Jian-Min Yuan; Thomas W Kensler; Sanja Dacic; Douglas J Hartman; Renwei Wang; Paula A Balogh; Pamela Sufka; Melissa A Turner; Kimberly Fuhrer; Lindsey Seigh; Yen Thi-Hai Pham; Jennifer Adams-Haduch; Giuseppe Valacchi; Giuseppe Valacchi; Shivendra V Singh; James G Herman; David O Wilson
2025
In plain language
Oral sulforaphane for 12 months significantly reduced Ki-67 proliferation marker in bronchial tissue of former smokers at high lung cancer risk.
- Evidence
- Established
- Design
- Randomized controlled trial
Cite this record: https://thecellwell.org/studies/HH-195408
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.